U-Systems raises $16.5m in funding:
This article was originally published in Clinica
Developer of automated breast ultrasound systems U-Systems (San Jose, California) has raised an additional $16.5m in a series D financing round, bringing total funding to $44.5m. The new round, led by Siemens Venture Capital, enables U-Systems to expand sales and marketing of its FDA-cleared and CE-marked SomoVu automated breast ultrasound system, and continue investing in product development. Existing investors Sycamore Venture Capital, MDS Capital, Radius Ventures, Kinetic Capital and United Investments contributed to the round, as did new shareholders President International Development Corporation, iD Innovation, China Investment & Development Company and TSC Bioventures.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.